Changes in myofilament proteins, but not Ca 2+ regulation, are associated with a high-fat diet-induced improvement in contractile function in heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 4, 2011, Pages

  Cheng, Y ^a   Li, W ^b   McElfresh, T A ^a   Chen, X ^a   Berthiaume, J M ^a   Castel, L ^c   Yu, X ^b   van Wagoner, D R ^c   Chandler, M P ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Case Western Reserve University   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Calcium; Contractile function; Dietary fat

Indexed keywords

CALCIUM ION; FATTY ACID; GLUCOSE; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PHOSPHOLAMBAN; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ECHOCARDIOGRAPHY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART HYPERTROPHY; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; MALE; MYOFILAMENT; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CALCIUM; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CORONARY VESSELS; DIET; DIETARY FATS; ELECTROCARDIOGRAPHY; HEART FAILURE; HEMODYNAMICS; LIGATION; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; MYOFIBRILS; MYOSIN HEAVY CHAINS; PHOSPHORYLATION; RATS; RATS, WISTAR;

EID: 80053268409     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00440.2011     Document Type: Article

References (51)

1. Anand IS, Liu D, Chugh SS, Prahash AJC, Gupta S, John R, Popescu F, Chandrashekhar Y. Isolated myocyte contractile function is normal in postinfarct remodeled rat heart with systolic dysfunction. Circulation 96: 3974-3984, 1997.
2. 2+ channel activity by a tyrosine kinase-independent mechanism. Mol Pharm 62: 554-565, 2002.
3. Bers DM. Altered cardiac myocyte Ca regulation in heart failure. Physiology 21: 380-387, 2006.
4. Berthiaume JM, Bray MS, McElfresh TA, Chen X, Azam SM, Young ME, Hoit BD, Chandler MP. Myocardial contractile response to physiological stress improves with high saturated fat feeding in heart failure. Am J Physiol Heart Circ Physiol 299: H410-H421, 2010.
5. Carnes CA, Janssen PML, Ruehr ML, Nakayama H, Nakayama T, Haase H, Bauer JA, Chung MK, Fearon IM, Gillinov AM, Hamlin RL, Van Wagoner DR. Atrial glutathione content, calcium current, and contractility. J Biol Chem 282: 28063-28073, 2007.
6. Caton SJ, Bai YL, Burget L, Spangler LJ, Tschop MH, Bidlingmaier M. Low-carbohydrate high-fat diets: regulation of energy balance and body weight regain in rats. Obesity 17: 283-289, 2009.
7. Christopher BA, Huang HM, Berthiaume JM, McElfresh TA, Chen X, Croniger CM, Muzic RF, Chandler MP. Myocardial insulin resistance induced by high fat feeding in heart failure is associated with preserved contractile function. Am J Physiol Heart Circ Physiol 299: H1917-H1927, 2010.
8. 2+ handling in adult control and ob/ob cardiomyocytes. Diabetes 56: 1136-1142, 2007.
9. 2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy. Circ Res 104: 95-103, 2009.
10. Gupta S, Prahash AJC, Anand IS. Myocyte contractile function is intact in the post-infarct remodeled rat heart despite molecular alterations. Cardiovasc Res 48: 77-88, 2000.
11. 2+ channels in canine tachycardia-induced heart failure. Cardiovasc Res 49: 298-307, 2001.
12. Hefti MA, Harder BA, Eppenberger HM, Schaub MC. Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol 29: 2873-2892, 1997.
13. Herron TJ, McDonald KS. Small amounts of α -myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ Res 90: 1150-1152, 2002.
14. Holt E, Tønessen T, Lunde PK, Semb SO, Wasserstrom JA, Sejersted OM, Christensen G. Mechanisms of cardiomyocyte dysfunction in heart failure following myocardial infarction in rats. J Mol Cell Cardiol 30: 1581-1593, 1998.
15. 2+ in the C57BL/6J mouse. Mol Cell Biochem 273: 87-95, 2005.
16. Hu FB. Diet and cardiovascular disease prevention: the need for a paradigm shift. J Am Coll Cardiol 50: 22-24, 2007.
17. Huang JM, Xian H, Bacaner M. Long-chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci USA 89: 6452-6456, 1992.
18. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479, 2009.
19. Huss JM, Kelly DP. Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest 115: 547-555, 2005.
20. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW, Kris-Etherton P, Goldberg IJ, Kotchen TA, Lichtenstein AH, Mitch WE, Mullis R, Robinson K, Wylie-Rosett J, Jeor SS, Suttie J, Tribble DL, Bazzarre TL. AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102: 2284-2299, 2000.
21. Layland J, Cave AC, Warren C, Grieve DJ, Sparks E, Kentish JC, Solaro RJ, Shah AM. Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I. FASEB J 19: 1137-1139, 2005.
22. LeWinter M. Functional consequences of sarcomeric protein abnormalities in failing myocardium. Heart Fail Rev 10: 249-257, 2005.
23. Listenberger LL, Schaffer JE. Mechanisms of lipoapoptosis: implications for human heart disease. Trends Cardiovasc Med 12: 134-138, 2002.
24. Lopaschuk GD, Ussher JR, Folmes CDL, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 90: 207-258, 2010.
25. McMullen JR, Shioi T, Huang WY, Zhang L, Tarnavski O, Bisping E, Schinke M, Kong S, Sherwood MC, Brown J, Riggi L, Kang PM, Izumo S. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase (p110 α) pathway. J Biol Chem 279: 4782-4793, 2004.
26. Mercadier J, Lompre A, Wisnewsky C, Samuel J, Bercovici J, Swynghedauw B, Schwartz K. Myosin isoenzyme changes in several models of rat cardiac hypertrophy. Circ Res 49: 525-532, 1981.
27. Mitov MI, Holbrook AM, Campbell KS. Myocardial short-range force responses increase with age in F344 rats. J Mol Cell Cardiol 46: 39-46, 2009.
28. Morgan EE, Faulx MD, McElfresh TA, Kung TA, Zawaneh MS, Stanley WC, Chandler MP, Hoit BD. Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction. Am J Physiol Heart Circ Physiol 287: H2049-H2053, 2004.
29. 2+ release and contraction during heart failure progression in postinfarction mice. Am J Physiol Heart Circ Physiol 296: H1069-H1079, 2009.
30. Okere IC, Chess DJ, McElfresh TA, Johnson J, Rennison J, Ernsberger P, Hoit BD, Chandler MP, Stanley WC. High-fat diet prevents cardiac hypertrophy and improves contractile function in the hypertensive Dahl salt-sensitive rat. Clin Expl Pharm Physiol 32: 825-831, 2005.
31. Okere IC, Young ME, McElfresh TA, Chess DJ, Sharov VG, Sabbah HN, Hoit BD, Ernsberger P, Chandler MP, Stanley WC. Low carbohydrate/ high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension. Hypertension 48: 1116-1123, 2006.
32. Palmer B. Thick filament proteins and performance in human heart failure. Heart Fail Rev 10: 187-197, 2005.
33. Panchal AR, Stanley WC, Kerner J, Sabbah HN. Beta-receptor blockade decreases carnitine palmitoyl ttransferase i activity in dogs with heart failure. J Card Fail 4: 121-126, 1998.
34. Ren J, Wold LE. Measurement of cardiac mechanical function in isolated ventricular myocytes from rats and mice by computerized video-based imaging. Biol Proc Online 3: 43-53, 2001.
35. Rennison JH, McElfresh TA, Okere IC, Patel HV, Foster AB, Patel KK, Stoll MS, Minkler PE, Fujioka H, Hoit BD, Young ME, Hoppel CL, Chandler MP. Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure. Cardiovasc Res 79: 331-340, 2008.
36. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipid 14: 281-287, 2003.
37. Schroder F, Handrock R, Beuckelmann DJ, Hirt S, Hullin R, Priebe L, Schwinger RH, Weil J, Herzig S. Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation 98: 969-976, 1998.
38. Sharma N, Okere IC, Duda MK, Chess DJ, O'Shea KM, Stanley WC. Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy. Cardiovasc Res 73: 257-268, 2007.
39. Sjaastad I, Bokenes J, Swift F, Wasserstrom JA, Sejersted OM. Normal contractions triggered by ICa,L in ventricular myocytes from rats with postinfarction CHF. Am J Physiol Heart Circ Physiol 283: H1225- H1236, 2002.
40. Solaro RJ, Kobayashi T. Protein phosphorylation and signal transduction in cardiac thin filaments. J Biol Chem 286: 9935-9940, 2011.
41. Swynghedauw B. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol Rev 66: 710-771, 1986.
42. Taegtmeyer H, Sen S, Vela D. Return to the fetal gene program. Ann NY Acad Sci 1188: 191-198, 2010.
43. Taegtmeyer H, Stanley WC. Too much or not enough of a good thing? cardiac glucolipotoxicity versus lipoprotection. J Mol Cell Cardiol 50: 2-5, 2010.
44. Taegtmeyer H, Wilson CR, Razeghi P, Sharma S. Metabolic energetics and genetics in the heart. Ann NY Acad Sci 1047: 208-218, 2005.
45. Tardiff JC, Hewett TE, Factor SM, Vikstrom KL, Robbins J, Leinwand LA. Expression of the β (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am J Physiol Heart Circ Physiol 278: H412-H419, 2000.
46. van der Meer P, Lipsic E, Henning RH, Boddeus K, van der Velden J, Voors AA, van Veldhuisen DJ, van Gilst WH, Schoemaker RG. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J Am Coll Cardiol 46: 125-133, 2005.
47. VanBuren P, Harris DE, Alpert NR, Warshaw DM. Cardiac V1 And V3 myosins differ in their hydrolytic and mechanical activities in vitro. Circ Res 77: 439-444, 1995.
48. Warren CM, Greaser ML. Method for cardiac myosin heavy chain separation by sodium dodecyl sulfate gel electrophoresis. Anal Biochem 320: 149-151, 2003.
49. Young ME, Yan J, Razeghi P, Cooksey RC, Guthrie PH, Stepkowski SM, McClain DA, Tian R, Taegtmeyer H. Proposed regulation of gene expression by glucose in rodent heart. Gene Regul Syst Bio 1: 251-262, 2007.
50. Yue P, Long CS, Austin R, Chang KC, Simpson PC, Massie BM. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype. J Mol Cell Cardiol 30: 1615-1630, 1998.
51. Zhang XQ, Moore RL, Tillotson DL, Cheung JY. Calcium currents in postinfarction rat cardiac myocytes. Am J Physiol Cell Physiol 269: C1464-C1473, 1995.